Navigation Links
UCSF stem cell, cancer scientist honored for pioneering studies
Date:6/15/2011

UCSF's Robert Blelloch, MD, PhD, has received the 2011 Outstanding Young Investigator Award from the International Society for Stem Cell Research, for his pioneering research on the role of molecular tools known as microRNAs in embryonic stem cells and cancer.

Blelloch will present his research today, June 15, 2011, at the opening of the ISSCR annual meeting in Toronto (6 p.m. EDT). He will participate in a press briefing at ISSCR tomorrow, June 16 (noon EDT).

MicroRNAs play a subtle, but key, role in regulating the production of proteins, which carry out all cell functions. After a gene's message has been transcripted into messenger RNA, microRNA binds a particular site on the mRNA and ratchets down the amount of protein it produces.

In recent years, research on the role of microRNAs in stem cells and cancer has "exploded," said Blelloch, a member of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at the University of California, San Francisco.

Thanks in part to his team, scientists now know that microRNAs are part of the molecular framework that determines an embryonic stem cell's fate. The cell either will duplicate its genetic material and divide into two identical copies of itself, thus "self renewing," or it will begin to differentiate as a particular type of adult cell, say, a heart muscle cell.

Scientists also know that faulty microRNA function allows unregulated stem cell growth, contributing to cancers. These molecular tools regulate the switch between proliferation and differentiation in both stem cells and cancer.

There are many hundreds of microRNAs, with different roles. Furthermore, each microRNA influences hundreds of messenger RNAs, exerting significant influence on the cell.

During the last few years, Blelloch's team has reported several key findings. In 2008, they reported that microRNAs promote self renewal of embryonic stem cells in mice (Natu
'/>"/>

Contact: Jennifer O'Brien
jennifer.obrien@ucsf.edu
415-502-6397
University of California - San Francisco
Source:Eurekalert  

0

GOOD

Page: 1 2 3

Related biology news :

1. Landmark study unlocks stem cell, DNA secrets to speed therapies
2. Stem cell, artificial liver research receives Coulter Foundation funding at NJIT
3. Blood stem cell, leukemia link illuminated in UCSF-led study
4. McLean Hospital researchers awarded $1.9 9 million grant for stem cell, blood research
5. Go figure: Math model may help researchers with stem cell, cancer therapies
6. How disordered proteins spread from cell to cell, potentially spreading disease
7. Breast cancer treatment resistance linked to signaling pathway
8. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
9. The dietary supplement genistein can undermine breast cancer treatment
10. Saliva proteins could help detection of oral cancer
11. Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UCSF stem cell, cancer scientist honored for pioneering studies
(Date:5/18/2013)... today at Digestive Disease Week (DDW) explores new discoveries ... of coffee on autoimmune disease and palliative care for ... been associated with reduced risk of fibrosis, a new ... java each month also correlate with lower risk for ... Clinic, Rochester, MN, linked coffee consumption with reduced risk ...
(Date:5/17/2013)... AGA Research Foundation announced a new grant that intends ... microbiota, one of today,s most exciting areas of science, ... Research Awards Panel selected Andrew T. Chan, MD, MPH ... Medical School, Boston, as the 2013 AGA-Elsevier Gut Microbiome ... of funding, commencing in July 2013, to test the ...
(Date:5/17/2013)... Atlanta residents of all ages will celebrate the ... impact on our daily lives during the inaugural ... engineers and educators from local museums, corporations, K-12 ... than 40 different events for children and adults ... http://atlantasciencefestival.org . , The annual Atlanta ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2New gut microbiome research to explore red meat -- colorectal cancer pathway 2First Atlanta Science Festival set for 2014 2
... study led by Boston University School of Public Health ... decongestants during their pregnancies are less likely to give ... than 37 weeks, gestation -- is the leading ... but its causes remain largely unknown, said Rohini Hernandez, ...
... 30 August 2010 The coming weeks mark the return ... satisfaction of making new friends and obtaining good test scores ... some school-aged adolescents. The previous decade has witnessed a two-fold ... 12 to 17. 1,2 In an effort ...
... often take communication courses unrelated to their major or ... up with the Library and English Departments to develop ... understand literature searchers and incorporate them into papers and ... Gail R. Nonnecke, Iowa State University faculty from the ...
Cached Biology News:BUSPH study observes link between decongestant use in pregnant women and lower risk of preterm birth 2School-based intervention successfully lowers drinking rates in at risk children 2Teaching communication and information literacy skills 2
(Date:5/19/2013)... MA (PRWEB) May 19, 2013 The ... social media training online, has proudly announced that the ... small business has surpassed 175,000 views on YouTube. The ... social media and SEO tips and training for small ... my students find the YouTube tips helpful for their ...
(Date:5/17/2013)... recipient,s immune system identifies the transplanted organ as foreign ... T cells, the immune cells that mediate rejection, must ... order to migrate to the transplanted organ. In this ... Fadi Lakkis and colleagues at the University of Pittsburgh ... cells is not required for migration. Instead, these cells ...
(Date:5/17/2013)... 2013 •    First of its kind research ... ,     New facility will help solve crop stresses ... Syngenta unveiled its new crop research facility during ... Innovation Center. The first of its kind, $72 million ... agricultural climate and precisely measure plant inputs – the ...
(Date:5/17/2013)... 17, 2013 /PRNewswire-iReach/ -- Aridis is pleased to ... Switzerland -based Kenta Biotech to ... antibody (mAb) products, and technologies. This asset portfolio ... treatment of infections by common pathogens including drug ... Pseudomonas aeruginosa , Acinetobacter baumannii ...
Breaking Biology Technology:YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3
... tea, soda and hot chocolate present risk, ... daily caffeine,during pregnancy -- whether from coffee, tea, ... risk of miscarriage, according a new study,by the ... for,the first time, pregnancy-related symptoms of nausea, vomiting ...
... antiviral activity in patients with ... NNRTI-resistant virus ... and Drug,Administration (FDA) has granted accelerated approval to the anti-HIV,medication ... to show antiviral activity in,treatment- experienced adult patients with HIV ...
... 18 Eli Lilly and Company,strongly objects to implications ... company has suppressed results of negative clinical,trials., The ... England Journal of,Medicine (NEJM), cited Prozac and Lilly as ... trial data. Not only was,the Times, story inaccurate when ...
Cached Biology Technology:Kaiser Permanente Study Shows Newer, Stronger Evidence That Caffeine During Pregnancy Increases Miscarriage Risk 2Kaiser Permanente Study Shows Newer, Stronger Evidence That Caffeine During Pregnancy Increases Miscarriage Risk 3Kaiser Permanente Study Shows Newer, Stronger Evidence That Caffeine During Pregnancy Increases Miscarriage Risk 4FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 2FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 3FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 4FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 5FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 6FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 7FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 8In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 2In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 3In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 4
NuParaffin Kit Application: Flow Cytometry Reactivity: Human...
Request Info...
...
Highly efficient electroporation solution suitable for transfection of plasmid DNA, oligonucleotides and siRNA. Compatible with all common electroporators....
Biology Products: